Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISION: ICG Fluorescence Imaging vs Standard Assessment for Flap Perfusion in Head and Neck Reconstruction
NCT07635420Phase 4Recruiting
- Sponsor
- Region Skåne
- Start
- Sep 2026
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
A Phase 4 trial of indocyanine green in 19p13.3 microduplication syndrome, sponsored by Region Skåne. Started Sep 2026; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
19p13.3 microduplication syndrome
Beyond the preview
Go deeper on NCT07635420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07635420.